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Abstract
The pancreas is comprised of exocrine and endocrine compartments releasing digestive enzymes into the duodenum
and regulating blood glucose levels by insulin and glucagon release. Tissue homeostasis is depending on transcription
factor networks, involving Ptf1α, Ngn3, Nkx6.1, and Sox9, which are already activated during organogenesis. However,
proper organ function is challenged by diets of high sugar and fat content, increasing the risk of type 2 diabetes and
other disorders. A detailed understanding of processes that are important for homeostasis and are impaired during
type 2 diabetes is lacking. Here, we show that Zeb1—a transcription factor known for its pivotal role in epithelial-
mesenchymal transition, cell plasticity, and metastasis in cancer—is expressed at low levels in epithelial cells of the
pancreas and is crucial for organogenesis and pancreas function. Loss of Zeb1 in these cells result in an increase of islet
mass, impaired glucose tolerance, and sensitizes to develop liver and pancreas steatosis during diabetes and obesity.
Interestingly, moderate overexpression of Zeb1 results in severe pancreas agenesis and lethality after birth, due to islet
insufficiency and lack of acinar structures. We show that Zeb1 induction interferes with proper differentiation, cell
survival, and proliferation during pancreas formation, due to deregulated expression of endocrine-specific
transcription factors. In summary, our analysis suggests a novel role of Zeb1 for homeostasis in epithelial cells that is
indispensable for pancreas morphogenesis and proper organ function involving a tight regulation of Zeb1 expression.
Introduction
Proper pancreas organ function and homeostasis is highly
challenged by the life style and diets of modern societies,
leading to continuously raising disorders like type 2 diabetes,
pancreatitis, and pancreatic cancer1–4. The pancreas is
organized in an exocrine compartment, producing and
releasing digestive enzymes into the intestine, and an
endocrine compartment, i.e., the islets of Langerhans2.
Endocrine cells regulate glucose concentrations in the blood
by insulin and glucagon releasing β- and α-cells, respec-
tively5,6. Although endocrine cells are very adaptable to
different metabolic demands, the pancreas is vulnerable to
continuous diets with high carbohydrates and fat content2.
Consequently, type 2 diabetes is constantly rising, which is
characterized by reduction of the insulin-producing β-cell
mass, insulin production/secretion, loss of sensitivity to
insulin, liver and pancreas steatosis and inflammation. To
identify more efficient treatment options a more detailed
understanding of pancreas organogenesis and function is
needed.
During development the pancreas in mice is specified at
E9.0 by budding from the ventral foregut endoderm into
dorsal and ventral parts that eventually fuse at E12.51,5,6.
Pdx1 expression is initiated in multiprogenitor cells that
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are specified by local repression of Shh, involving activin,
retinoic acid, FGF, and BMP signals1,5,6. Pdx1, Ptf1α, and
Sox9 are crucial for pancreas organogenesis and loss of
any of these factors results in agenesis or hypoplasia7–10.
During primary transition until E12.5 FGF10 signaling
from the underlying mesoderm promotes Ptf1a and Sox9
expression to form tip (acini progenitors) and trunk cells
(endocrine and duct progenitors)11–13. Ptf1α and Nkx6.1/
Nkx6.2 specify tip and trunk cells, respectively, by
repressing each other’s expression, orchestrated by the
Notch pathway5,12,14–16. Secondary transition is initiated
at E12.5 and lasts until E16.5, involving continued
branching morphogenesis and specification of tip cells
into acini by E15.5 and of endocrine progenitors by
delamination of individual Ngn3+ cells from the mono-
layer epithelium of the trunk to form islets1,11,16–19.
During the second transition Ptf1α, Pdx1 and Sox9
become restricted to acini, islets and ducts, respectively6.
Endocrine cell delamination requires activation of
epithelial-mesenchymal transition (EMT)20, a program
that is activated also during tumorigenesis by EMT
transcription factors including Snail, Slug, and Zeb1/2.
Zeb1 is well known for regulating tumorigenesis, metas-
tasis, and therapy resistance21–27. Activation of Zeb1
induces a transient loss of epithelial characteristics and a
gain of mesenchymal traits enabling cell motility and
malignancy24,26,28. We recently identified that, although
Zeb1 is almost undetectable in normal epithelia and
tumor cells before EMT, an intact Zeb1 allele promotes
initiation and progression of precancerous lesions of the
pancreas (PanINs)22. During embryogenesis and in adult
tissues, Zeb1 is mainly confined to neuronal and meso-
dermal lineages, whereas epithelia display only weak or no
Zeb1 expression29,30. Zeb1 knockout embryos show
severe skeletal defects, impaired neural tube closure, and
die perinataly29,31. Zeb1 is involved in the cell-type spe-
cification, tissue function, and regeneration, including
muscle, bone, and melanocyte differentiation32–35. How-
ever, not much is known about Zeb1 function in epithelia.
Here, we analyzed the role of Zeb1 during pancreas for-
mation and homeostasis using loss- and gain of function
approaches in mice. We found that Zeb1 is involved in the
maintenance of tissue homeostasis and protects the pan-
creas from accelerated tissue damage during metabolic
disorders, like diabetes mellitus. Moreover, our data
indicate that Zeb1 levels need to be tightly regulated to
form and maintain a pancreas with appropriate acinar to
islet ratios and to avoid tissue damage.
Results
Depletion of Zeb1 in the embryonic pancreas results in
increased organ weight
We explored Zeb1 expression in non-mesenchymal
cells by using the zygotic Zeb1 knockout29. Besides strong
expression of Zeb1 in the brain, neural tube, and
mesoderm-derived tissues, we detected weak expression
in the pancreas epithelial compartment, which was lost in
Zeb1 knockout embryos (Suppl. Fig. S1A). To specifically
target Zeb1 in these cells we used conditional gene abla-
tion by Pdx1-Cre29,36 starting from E8.5. Efficient, but not
always uniform recombination was observed with the
mTmG Cre-reporter allele (Suppl. Fig. S1B)37 and Pdx1-
Cre mediated Zeb1 depletion (hereafter Zeb1Δ/Δpanc) was
restricted to the pancreas epithelium, including acini,
ducts, and islets (Suppl. Fig. S1B). No obvious mal-
formation or atrophy was found upon Zeb1 loss (Fig. 1A).
However, mutant mice displayed an increase in pancreas
mass, albeit significant only at six months of age due to
high individual variability (Fig. 1B, left). Such alterations
were not observed in other organs (Fig. 1B, right). At six
months heterozygous mice also showed a trending
increase in pancreas mass (Fig. 1B). Tissue architecture
and abundance of the exocrine compartment (acini and
intralobular ducts) and endocrine islets of Langerhans
were not affected (Fig. 1C). We detected an increase in
proliferation by Ki67 and a reduced, but not yet sig-
nificant, level of apoptosis by cleaved Caspase 3 immu-
nohistochemistry in pancreata of Zeb1Δ/Δpanc animals. In
adult pancreata epithelial-specific Zeb1 expression was
confined to only individual acinar and islet cells, but was
absent in Zeb1-deficient mice. Yet, no effect of Zeb1
depletion on protein expression of bona fide Zeb1 target
genes, like E-cadherin (E-cad), was detected (Fig. 1D).
These results show that Zeb1 is expressed at low levels
in pancreas epithelial lineages during development and in
adult mice and that Zeb1 depletion results in increased
organ weight likely supported by imbalanced proliferation
and apoptosis rates.
Zeb1 deficiency affects normal function of the endocrine
pancreas
Combined with an increase in organ mass Zeb1Δ/Δpanc
mice showed elevated Insulin-positive islet β-cell areas
(Fig. 2A). To address whether this increase in islet mass had
also functional impact on blood glucose regulation we
subjected Zeb1fl/fl and Zeb1Δ/Δpanc littermates to an intra-
peritoneal glucose tolerance test (GTT)38. As expected,
intraperitoneal (i.p.) injection of 2 g/kg body weight glucose
raised blood glucose levels to ~150% in control mice (Fig.
2B, gray line), which declined to pre-injection levels within
120min. In contrast, glucose levels increased up to 200% in
Zeb1Δ/Δpanc littermates (Fig. 2B, red line) and remained
higher than those of control mice until 60min post glucose
injection, indicating that acute endocrine function was
impaired upon Zeb1 loss. Interestingly, Insulin concentra-
tions also showed a higher, but still not significant peak in
Zeb1Δ/Δpanc mice, whereas they trend to be slightly reduced
before fasting and GTT (t= 0; Fig. 2C) as well as in
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Fig. 1 Depletion of Zeb1 in the epithelium of the embryonic pancreas results in increased pancreas mass in adult mice. A Strategy of
pancreas-specific Zeb1-depletion in acinar, ductal, and endocrine lineages by combining Pdx1-Cre and Zeb1flox alleles in Zeb1Δ/Δpanc mice. B Analysis
of pancreas to body weight and spleen to body weight ratios in 3, 6 and 12+-month-old mice, demonstrating a pancreas-specific increase in organ
size at 6 months of age. n= 6 (3 months), n= 11–16 (6 months), n= 11–13 (12+months). C Histological (HE) and anti-Ki67/anti-cleaved Caspase 3
immunhistochemical stainings on paraffin-embedded pancreas sections of 6-month-old mice with summary graphs of quantification of proliferating
and apoptotic cell fractions. Arrowheads indicate examples of positively stained cells. bv, blood vessel; id, intralobular duct; isl, islet of Langerhans.
n= 6 (Ki67), n= 3 (cl. Casp. 3). Scale bars, 100 µm (HE) and 50 µm (IHC). D anti-Zeb1 immunohistochemistry and anti-E-cadherin (E-cad)
immunofluorescence staining, showing proper Zeb1 loss in epithelial cells in acini and islets of Langerhans of 6-month-old Zeb1Δ/Δpanc pancreata
without affecting the expression of E-cad as one major Zeb1 target. Arrowheads and open arrowheads indicate Zeb1-positive epithelial and
mesenchymal cells, respectively. Scale bars, 100 µm (upper), 25 µm (lower IHC), 50 µm (upper) and 25 µm (lower IF). Statistical significance was
determined by two-way ANOVA and indicated if significance was reached. *p= 0.0194 (B); *p= 0.0280 (C).
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untreated, non-fasting mice (Suppl. Fig. S2A). The low-
affinity glucose transporter, Glut2 regulates membrane
depolarization and Insulin granule fusion with the plasma
membrane in β-cells; one key step in blood glucose level
sensing39. In accordance with the increased area of islets we
detected also a trend towards increased Glut2-positive areas
in Zeb1Δ/Δpanc mice but no deregulation within individual
cells or islets (Fig. 2A). Pancreas bulk mRNA analysis
revealed no significant decrease in Zeb1 transcript levels and
no changes in Zeb1-regulated targets, like E-cad (Cdh1) and
Vimentin (Vim) (Fig. 2D), owing to the major contribution
of Zeb1 expression in the pancreas by mesenchymal cells not
targeted by Pdx1-Cre. A specific lineage marker for acinar
cells, Amylase (Amy2), was unchanged, whereas the ductal
Fig. 2 Zeb1 in the pancreas is crucial for regulating islet mass and function. A Immunhistochemical staining of islets of Langerhans by anti-
Insulin and anti-Glut2 in pancreata of 6-month-old mice, revealing an increase in islet mass upon Zeb1 depletion. n= 6–8 (Insulin), n= 7 (Glut2).
Scale bars, 500 µm and 100 µm (inset). B, C Intraperitoneal glucose tolerance test (GTT) in Zeb1Δ/Δpanc and Zeb1fl/fl littermates at 6 months of age and
measurement of relative glucose (B, left) and insulin levels in venous blood over time (C, left), as well as absolute glucose (B, right) and insulin levels
(C, right) before injection (t= 0). n= 7. D qRT-PCR analysis of Zeb1Δ/Δpanc, Zeb1+/Δpanc and Zeb1fl/fl pancreas mRNA at 6 months detecting EMT
markers and lineage-specific genes (Amy2, acinar; Hes1, ductal; Pdx1, Ngn3, Nkx6-1, Ins2, Gcg, endocrine), demonstrating that specifically endocrine
marker genes are differentially expressed in Zeb1Δ/Δpanc mutant mice. n= 3. Statistical significance was determined by two-way ANOVA (qRT-PCR),
one-way ANOVA (Insulin, Glut2), unpaired two-tailed multiple (GTT) or single Student’s t-test (GTT, t= 0) and indicated if significance was reached.
***p= 0.0003, p < 0.0001 (A); *p= 0.0197 (B); **p= 0.0086; *p= 0.0407, p= 0.0452, p= 0.0425 (D).
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marker and Notch target Hes1 was increased in Zeb1Δ/Δpanc
pancreata. Although the endocrine lineage and differentia-
tion transcription factor Pdx1 was not altered, two down-
stream transcription factors for β-cell differentiation, were
either significantly upregulated (Ngn3) or tended to be
reduced (Nkx6-1) in mutants (Fig. 2D).
In summary, our findings show that cell composition is
shifted in the Zeb1Δ/Δpanc pancreata towards an increase
of islet β-cell mass, combined with altered endocrine
marker gene expression likely causing systemic impair-
ment on sensing/processing of blood glucose levels.
Zeb1 depletion reveals metabolic changes in diabetic mice
To discriminate Zeb1 function between endocrine and
exocrine compartments we challenged the pancreas by
induction of type 2 diabetes40 and chronic pancreatitis (CP).
Mice subjected to high-fat diet (HFD) for 19 weeks devel-
oped type 2 diabetes, dramatically gained body weight (Fig.
3A, Suppl. Fig. S2B), and displayed elevated blood glucose
levels by the trend in comparison to normal diet (ND)-fed
mice. Moreover, a two to eightfold but not yet significant
increase in steady-state Insulin levels was detected (Fig. 3B,
Suppl. Fig. S2C–E), suggesting insulin resistance. In general,
males were more susceptible to gain body weight than
females and individuals show varying consequential effects.
Although no apparent differences in body weight, blood
glucose, and insulin levels were observed between the gen-
otypes, only Zeb1Δ/Δpanc animals showed a tendency of
retaining high glucose levels after the short period of fasting
prior to GTT (Suppl. Fig. S2D). Upon increasing baseline
glucose levels (t= 0) HFD-fed diabetic Zeb1Δ/Δpanc mice
displayed no change in the glucose peak at 15min after
glucose injection and the diabetes-dependent impairment of
glucose clearance (Fig. 3C, Suppl. Fig. S2F). Importantly,
HFD-fed Zeb1Δ/Δpanc mice exhibited increased liver weight
(Fig. 3D, Suppl. Fig. S2G). Despite high variability, we con-
sistently found higher fractions of them displaying lipid
deposition in the pancreas (≥40%, three out of six vs. one out
of six mice) and apparent liver steatosis (≥40%, three out of
six vs. two out of six mice; Fig. 3E–G, Suppl. Fig. S2G, H). Of
note, Zeb1Δ/Δpanc males showed trending increased liver
steatosis, but decreased pancreas lipid content in compar-
ison to their control littermates, whereas Zeb1Δ/Δpanc
females showed inverted effects (Suppl. Fig. S2I).
To challenge the exocrine compartment in Zeb1Δ/Δpanc
mice, we performed hydrodynamic gene delivery of a
constitutive Il17a expression vector to induce pancreati-
tis41. CP was detected in Zeb1fl/fl and Zeb1Δ/Δpanc indivi-
duals 15 days post injection, accompanied by massive
tissue damage, especially of acinar cells, infiltration of
CD45+ hematopoietic cells, and fibrosis without major
differences (Suppl. Fig. S3).
In conclusion, Zeb1 deficiency mainly affects the
endocrine compartment, leading to altered glucose and
insulin levels that result in systemic effects by exacer-
bating disease pathology of type 2 diabetes including
accelerated liver steatosis.
Moderate induction of Zeb1 in the pancreas causes
agenesis
Zeb1 deletion in the pancreas affects pancreas home-
ostasis. To experimentally increase Zeb1 levels we made use
of the indZeb1 knock-in allele (R26-Zeb1tg), harboring Zeb1-
HA cDNA driven by the Rosa26 locus42 activated by Pdx1-
Cre in indZeb1 mice (Fig. 4A). To our surprise, these mice
died shortly after birth showing severe growth retardation
with only a few individuals reaching 2–7 weeks of age (Fig.
4B, C), due to pancreas agenesis to variable extend and
sporadic cyst formation. This observation was combined
with more severe reduction of the islet mass (Fig. 4C). To
discriminate whether moderate elevation of Zeb1 expression
impaired pancreas specification or affected cell survival later,
we analyzed E15.5 embryos, when the secondary transition
was almost completed in control embryos. Although the size
of the embryonic pancreas was slightly reduced, all indZeb1
embryos displayed a clearly discernible pancreas with proper
gross morphology but included sporadic cystic or blood-
filled structures (Fig. 4D). Zeb1 overexpression was con-
firmed by immunofluorescence staining, showing expression
at the detection limit, with a few patches of more robust
expression (Fig. 4E and inset). We observed a slight global
reduction in the expression of the Zeb1 target E-cad with
almost negative patches of higher Zeb1 levels in mutant
embryos (Fig. 4D). mRNA analysis of pancreata from
embryos and pups confirmed a moderate 1.5 and 3-fold
increase in Zeb1 transcripts resulting in lower Cdh1 and
higher Vim levels in indZeb1, whereas Zeb1 depletion had
no robust effect (Fig. 4F).
In summary, we established mice with an approximately
twofold ectopic Zeb1 expression in pancreas epithelial
cells that is incompatible with proper pancreas organo-
genesis resulting in agenesis at birth.
Proper pancreas morphogenesis in indZeb1 mice is
impaired during secondary transition
To identify how pancreas formation is compromised by
elevated Zeb1, we analyzed key developmental stages after
completion of the primary transition (E13.5), during (E15.5),
and after the secondary transition (E17.5) on a cellular level
in indZeb1 and Zeb1Δ/Δpanc embryos. Histological analysis
confirmed that the size of the pancreas of indZeb1 was
affected mainly during the secondary transition at E15.5 and
E17.5 to a varying extend (Fig. 5A). No apparent defects
were observed in Zeb1Δ/Δpanc pancreata throughout orga-
nogenesis (Fig. 5A). In Zeb1-proficient control (ctrl) and
Zeb1fl/fl littermates at E13.5 cellular differentiation into tip
and trunk cells was identified by HE staining (Fig. 5A, top
panel). In contrast, this proper morphological separation was
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not present in indZeb1 specimens. Here, we observed more
undifferentiated clusters of cells that became more promi-
nent at E15.5 and acinar morphogenesis was only initiated in
some areas of the pancreas (Fig. 5A, middle panel). More-
over, separation into individual lobes that were present at
E15.5 in ctrl and Zeb1fl/fl embryos was clearly lacking in
indZeb1 individuals. These developmental defects were
more pronounced at E17.5, when the pancreas was smaller
in indZeb1 embryos (Fig. 5A, lower panel, arrowheads),
although proper acinar and duct structures were found in
less affected areas. Reduction in organ size was reflected by a
trend to decreased proliferation and increased apoptosis
(Fig. 5B–D), whereas it was unchanged in Zeb1Δ/Δpanc
embryos.
Our findings indicate that ectopic Zeb1 expression is
interfering with secondary transition and blocks proper
lineage specification leading to an accumulation of
undifferentiated cells combined with indications of
impaired proliferation and increased apoptotic rates.
Elevated Zeb1 expression in the embryonic pancreas
interferes with proper endocrine differentiation
Next, we checked for lineage marker gene expression,
i.e., Ptf1α for tip/acinar cells, Sox9 for trunk/duct cells,
Fig. 3 Zeb1 loss results in systemic metabolic changes accompanied by increased lipid deposit in the pancreas and liver upon challenging
the endocrine pancreas. A Induction of type 2 diabetes by high-fat diet (HFD) over 19 weeks leads to rapid and similar body weight gain in
Zeb1Δ/Δpanc and Zeb1fl/fl littermates compared to normal chow diet (ND). n= 11–12 (HFD), n= 4 (ND). B Measurement of blood glucose and insulin
levels before and after HFD shows no difference between the genotypes. n= 6 (HFD), n= 2 (ND). C Intraperitoneal GTT in mice after the 19-week
HFD. n= 9 (HFD), n= 4 (ND). D Measurement of the liver to body weight ratios indicate a significant increase in Zeb1Δ/Δpanc liver mass compared to
Zeb1fl/fl littermates after HFD. n= 6 (HFD), n= 2 (ND). E, F Percentage of area that shows lipid content deposit by oil red O (ORO) staining on
cryosections (E) and liver steatosis on HE sections (F) of Zeb1Δ/Δpanc and Zeb1fl/fl mice after HFD. n= 6 (HFD), n= 2 (ND). G HE staining on paraffin
sections of the pancreas (upper panel) and liver (lower panel) of Zeb1Δ/Δpanc and Zeb1fl/fl mice after HFD or ND as well as detection of lipid droplets in
the pancreas by ORO on cryosections (middle panel), indicating a more severe phenotype in HFD-fed Zeb1Δ/Δpanc mice. Note, that pancreas and liver
HE sections are taken from the same mouse, whereas ORO stained sections are taken from a different individual. Open arrowheads indicate detection
of altered pancreas histology and arrowheads and dashed lines highlight liver steatosis. The absence of a dashed line indicator in the Zeb1Δ/Δpanc liver
(HFD) refers to the absence of normal liver tissue, whereas livers from ND-fed mice are devoid of liver steatosis. Scale bars, 100 µm. Statistical
significance was determined by two-way ANOVA and indicated if significance was reached. *p= 0.030.
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Fig. 4 (See legend on next page.)
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and Pdx1 and Glucagon for endocrine/α-cells. At E13.5
we found uniform expression of Ptf1α with a preference
to acinar/tip structures and Sox9 labeled trunk/duct/
endocrine progenitors in ctrl embryos (Fig. 6A, top panel).
indZeb1 embryos also displayed Ptf1α expression, but
slightly weaker, whereas Sox9 was less confined, indicat-
ing that lineage segregation was delayed or inhibited upon
Zeb1 induction (Fig. 6A, bottom panel). At the end of the
secondary transition at E15.5 Ptf1α properly decorated
acinar structures, Pdx1 and Glucagon were found in more
centrally located endocrine derivatives and Sox9 in ductal
cells of ctrl embryos (Fig. 6B, top panel, Suppl. Fig. S4A).
Upon Zeb1 overexpression acinar and duct cells were still
identified by Ptf1α and Sox9, respectively (Fig. 5B, bottom
panel, Suppl. Fig. S4A). However, we noticed a substantial
reduction of Pdx1 and Glucagon positive cells, indicating
a reduction of the endocrine lineage. This was most
apparent in patches of higher ectopic Zeb1 levels, in
which also E-cad was reduced, but without altering Ptf1α
and Sox9 expression (Fig. 6B, Suppl. Fig. S4A). Areas with
milder defects displayed proper tissue architecture with
proper marker gene expression (Fig. 6C, Suppl. Fig. S4B).
Nkx6.1 is a key transcription factor for lineage specifica-
tion in multiprogenitor cells in early stages and for islet
β-cell formation later during organogenesis43. In E13.5
ctrl pancreata Nkx6.1 labeled distinct epithelial trunk and
tip cell clusters and was continuously expressed until
E15.5 (Fig. 6D). In contrast, indZeb1 embryos showed
uniform expression of Nkx6.1 in more undifferentiated
cell clusters at E13.5 and E15.5 (Fig. 6D). At E17.5 the
number of Nkx6.1-positive cells was largely reduced in
indZeb1 compared to ctrl littermates (Fig. 6D).
This analysis demonstrates that pancreas cell differ-
entiation and morphogenesis are sabotaged by moderate
Zeb1 overexpression, mainly affecting the endocrine
lineage.
Zeb1 induction reduces expression of miR-200 family
members that are regulators of β-cell function
We analyzed transcript levels of marker genes in the
pancreas of indZeb1 and Zeb1Δ/Δpanc embryos and pups.
Ductal marker gene expression (Hes1) was almost
unchanged in all embryonic stages and genotypes. Amy2
(acini-specific) was initially increased, but reduced in
indZeb1 mutants between E15.5 and E17.5 (Fig. 7A, left).
Substantial changes were observed in markers of endo-
crine cells of indZeb1 embryos/pups at all analyzed stages.
Pdx1, Ngn3 (endocrine progenitors), Ins2, Gcg (β- and α-
cells, respectively), and Glut2 (Slc2a2, β-cells) were con-
sistently reduced to 10–50% of control levels, further
supporting the finding of a decisive impact of Zeb1
overexpression on the endocrine lineage (Fig. 7A, left).
Zeb1Δ/Δpanc pancreata showed a trending increase in the
expression of the β- and α-cell marker genes Ins2 and Gcg
at E17.5 and P2 concomitant to decrease in expression of
Slc2a2 at E15.5 and P2 (Fig. 7A, right). This finding was in
agreement with an increase in islet mass in Zeb1Δ/Δpanc
adult mice.
miRNAs play a crucial role in pancreas organogenesis
and homeostasis44. In particular, the miR-200 family is
important and forms a double-negative feedback loop
with Zeb1. High miR-200 levels downregulate Zeb1,
whereas increased Zeb1 expression represses miR-200s
expression affecting cellular differentiation45,46. In the
pancreas miR-200s are crucial for proper organ forma-
tion, but ectopic elevation results in islet β-cell apoptosis
in type 2 diabetes mice whereas depletion protects against
diabetic loss of β-cells47,48. In accordance with Zeb1-
mediated repression of miR-200s we found constantly
reduced expression of miR-429, miR-200a/c, and miR-
141, as well as of miR-203 in indZeb1, which was most
significant at E17.5 and P2 (Fig. 7B, left). Apparently, miR-
200 repression did not prevent islet and β-cell loss,
(see figure on previous page)
Fig. 4 Moderate experimental Zeb1 induction in the pancreas causes a moribund phenotype and pancreas agenesis. A Strategy to generate
indZeb1 mice. A targeted allele of the Rosa26 locus provides ectopic Zeb1 expression under Rosa26 cis-regulatory elements that is unleashed by Cre
activity to delete a loxP flanked PGK-neo-3xpA cassette. An internal ribosomal entry site (IRES) allows simultaneous expression of eGFP in recombined
cells. Zeb1 expression was directed to the developing pancreas from E8.5 onwards utilizing the Pdx1-Cre allele. B Kaplan–Meyer plot showing the
moribund phenotype of indZeb1 pups displayed already in early postnatal stages with only a few individuals surviving more than 4 weeks. n= 11
(ctrl), n= 20 (indZeb1). C Analysis of pups at P3 demonstrating severe growth retardation and pancreas agenesis. Scale bar, 5 mm (upper) and
100 µm (lower panels). D Isolated indZeb1 embryos at E15.5 show no developmental defects and a pancreas that is comparable in size of ctrls. Some
mutant embryos display cyst formation or hemorrhage. Scale bars, 1 mm (upper and middle) and 500 µm (lower panel). E Immunofluorescence
staining of Zeb1 and E-cadherin (E-cad) in the pancreas on sagittal cryosections of ctrl and indZeb1 embryos at E15.5, demonstrating that Zeb1 is
moderately induced throughout the pancreas epithelium with patches of more increased expression (inset). E-cad expression is reduced in indZeb1
embryos compared to ctrls. Embryos are oriented anterior to the top and dorsal to the right. Nuclei are stained with DAPI (blue). Scale bar, 100 µm.
F Detection of transcript levels of Zeb1, Cdh1 (E-cad), and Vim in embryonic pancreata between E13.5 and P2, demonstrating two to threefold
induction of Zeb1 in early stages of indZeb1 specimens, combined with slight Cdh1 reduction and Vim upregulation, whereas no change was
observed in Zeb1Δ/Δpanc individuals. n= 7–11 (E13.5, indZeb1), n= 5 (E13.5, Zeb1Δ/Δpanc); n= 7–9 (E15.5, indZeb1), n= 3–4 (E15.5, Zeb1Δ/Δpanc);
n= 5–6 (E17.5, indZeb1), n= 7–8 (E17.5, Zeb1Δ/Δpanc); n= 7–9 (P2, indZeb1), n= 5–6 (P2, Zeb1Δ/Δpanc). Statistical significance was determined by Log-
rank test (survival) or Student’s t-test (qRT-PCR) and indicated if significance was reached. ***p < 0.0001 (B); ***p < 0.001; **p= 0.007; *p= 0.012,
p= 0.022, p= 0.080 (F).
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Fig. 5 Pancreas organogenesis is impaired after primary transition in indZeb1 embryos. A HE staining of sagittal paraffin sections of embryos
of ctrl, indZeb1, Zeb1fl/fl, and Zeb1Δ/Δpanc genotypes between E13.5 and E17.5 as indicated. Whereas no morphological alterations were detected
upon Zeb1 depletion indZeb1 embryos show specific defects that include the presence of undefined cell aggregates/clusters that do not show
separation into tip/trunk cells or acini/duct/islet progenitors as present in control littermates (E13.5, E15.5), reduction of the expansion of the pancreas
in some embryos (all stages) and appearance of cyst-like structures (E17.5, open arrowheads). Scale bars, 100 µm (top and middle panels), 250 µm
(bottom panel). B Analysis of proliferation (anti-Ki67, anti-phH3) and apoptosis (anti-cleaved Caspase 3) and Zeb1 by immunohistochemical staining
on consecutive sections of ctrl, indZeb1, and Zeb1Δ/Δpanc embryos at E13.5 and E17.5. Arrowheads point to examples of positive cells in the epithelial
compartment. Note, that apoptotic cells are very rare and not found on every section or only in other organs (open arrowheads). Scale bar, 50 µm.
C, D Quantification of Ki67- (C) and cl. Casp. 3-positive cells (D) in indZeb1 and Zeb1Δ/Δpanc embryos in comparison to their corresponding control
littermates at indicated stages. Proliferation in indZeb1 individuals is reduced at E13.5 and E17.5, while apoptosis is increased at E15.5 and E17.5. No
difference was observed upon Zeb1 depletion. n= 4–8 (indZeb1), n= 4–6 (Zeb1Δ/Δpanc). All sections are oriented anterior to the top and dorsal to the
right. Scale bar, 50 µm. Statistical significance was determined by Student’s t-test and indicated if significance was reached. *p= 0.020.
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Fig. 6 Ectopic Zeb1 activation results in reduction of progenitors of the endocrine lineage. A Immunofluorescence labeling of Ptf1α (tip) and
Sox9 (trunk) on sagittal cryosections of indZeb1 and ctrl embryos at E13.5, showing Ptf1α and Sox9 staining in both genotypes, indicating that tip
and trunk cell specification is unaffected in indZeb1 embryos. However, a slightly reduced number of Ptf1α and Sox9 positive cells is detected in
indZeb1 embryos. Anti-E-cadherin staining (red) was used to visualize tissue architecture. Nuclei are labeled with DAPI (blue). Scale bar, 50 µm.
B Immunofluorescence labeling of Ptf1α (acinar), Pdx1 (endocrine), Glucagon (Gcg, islet β-cell progenitors), and Sox9 (duct) on sagittal cryosections
of indZeb1 and ctrl embryos at E15.5. Markers of all lineages are detected, however, specifically, the number of Pdx1 and Gcg-positive cells are
reduced in indZeb1 mutant embryos, indicating a specific loss of endocrine progenitors. Anti-Zeb1 and anti-E-cad labeling were used to visualize
cells with ectopic expression and tissue architecture, respectively. Insets show red channel only of the boxed region. Nuclei are labeled with DAPI
(blue). Scale bar, 100 µm. C Pseudo-overlay of consecutive sagittal cryosections, individually stained for either Ptf1α (acinar), Pdx1 (endocrine), or Sox9
(duct lineage). False colors were used to visualize the topological organization of the different cell lineages in the pancreas of indZeb1 and ctrl
embryos at E15.5. In indZeb1 the topological tissue organization is maintained, displaying Ptf1α-positive acinar structures on the outside with patches
of Pdx1-positive endocrine cells and Sox9-positive ducts in the center of the tissue. Scale bar, 100 µm. D Immunohistochemical staining of Nkx6.1 in
indZeb1 and ctrl embryos between E13.5 and E17.5. Nkx6.1 labels tip/trunk and acini/duct/endocrine progenitor cells after primary transition and
becomes confined to endocrine cells at later stages in ctrl embryos. In indZeb1 specifically, undefined unstructured accumulation of cells are all
stained positive for Nkx6.1, indicating a block in proper lineage segregation. Scale bar, 100 µm. All sections are oriented anterior to the top and dorsal
to the right.
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indicating additional dominating effects of a Zeb1
increase. Acinar and islet-specific loss of Zeb1 did not
induce detectable alterations in miRNA levels (Fig. 7B,
right). However, in adult Zeb1Δ/Δpanc mice, when islet
mass was increased, we observed a slight elevation of miR-
200s, reaching significance only for miR-200a (Suppl. Fig.
S5).
These results confirm that manipulation of Zeb1
expression mainly affects cells of the endocrine lineage
and altered endocrine marker gene expression likely
represents a shift in cell composition of the different
lineages. Activation and loss of Zeb1 affects Zeb1-targeted
miRNAs, but alterations in miR-200s cannot fully account
for the dramatic changes in pancreas morphogenesis and
function when Zeb1 is artificially increased or depleted.
Discussion
Tissue integrity and organ function of the pancreas is
dependent on a large variety of signaling cues, transcrip-
tion factors and metabolic crosstalk. A delicate equili-
brium of constant glucose levels in the blood is necessary
for homeostasis. This is regulated by ancient mechanisms
to cope with periods of poor and exuberant nutrition and
physical activity. Constant excess nutrition promotes
hyperglycemia, obesity, and type 2 diabetes1,2. Tran-
scription factor networks orchestrated by Pdx1, Ptf1α,
Sox9, Hnf1α, Gata4/6, Ngn3 are indispensable for mor-
phogenesis and homeostasis of the pancreas and loss of
any of these result in a moribund phenotype caused by
hypoplasia of islets1,5,6,12,49. Our analyses demonstrated
that pancreas organogenesis and function is also depen-
dent on Zeb1, a transcription factor mainly confined to
non-epithelial cells and a potent inducer of EMT. We
found that Zeb1 is expressed at low levels in the pancreas
primordium and in acinar and islet cells. Inactivation of
Zeb1 increases islet mass, levels of glucose and Insulin and
promotes liver steatosis. In contrast, a ~2-fold elevated
Zeb1 expression during embryogenesis blocks proper
differentiation and cell survival of acinar and islet pro-
genitors during the second transition leading to pancreas
agenesis and postnatal lethality. We show that Zeb1
expression needs to be tightly regulated for proper pan-
creas morphogenesis and organ function.
During development EMT-TFs are important to drive
key morphogenetic events26,28. While Snail induces EMT
during gastrulation, Zeb1 is needed for mesoderm-derived
differentiation processes at later stages, e.g., of bone,
muscle, and melanocytes23,31–34. The function of EMT-
TFs in normal epithelia might have been largely over-
looked due to their very prominent expression in meso-
derm and neurectoderm-derived cell types. In the
intestine Snail regulates differentiation and homeostasis,
since epithelial Snai1 depletion and overexpression result
in apoptotic loss and increase of crypt base columnar
cells, respectively50. Slug regulates stem/progenitor cells
and luminal differentiation in the epithelium during
mammary gland morphogenesis51. We add another level
of EMT-TF function in epithelia with a novel role of Zeb1
in the pancreas that requires tight regulation of expres-
sion. Of note, other EMT-TFs are also involved in pan-
creas formation. Ngn3 increases Snai1 and Snai2 (Slug)
expression post-transcriptionally in duct cells, which is
crucial for efficient Cdh1 downregulation and delamina-
tion of Ngn3+ endocrine progenitors20,50,52. In our
experiments, we did not detect a contribution of Zeb1 in
this process. Although experimental Zeb1 activation
resulted in decreased E-cad expression in the early pan-
creas, the reduction of all endocrine markers including
Ngn3 rather suggests inhibition of endocrine specification
by Zeb1. It implies that the role of Zeb1 in specification,
differentiation, proliferation, and survival of progenitor
cells is intricate and clearly differs from the functions of
Snail and Slug. This is in agreement with the non-
redundant functions of EMT-TFs in other contexts23.
(see figure on previous page)
Fig. 7 Zeb1 overexpression causes a dramatic decrease in expression of endocrine marker gene transcripts and affects Zeb1-regulated
microRNAs. A qRT-PCR analysis of specific lineage markers in pancreas mRNA of indZeb1/ctrl and Zeb1Δ/Δpanc/Zeb1fl/fl littermates between E13.5 and
P2. Consistent reduction of expression was observed in all endocrine-specific genes (Pdx1, Ngn3, Nkx6-1, Ins2, Gcg, Slc2a2) in indZeb1 embryos as well
as expression of exocrine-specific Amy2 is slightly reduced at E15.5 and E17.5, whereas expression of a ductal marker (Hes1) is unaffected. Zeb1Δ/Δpanc
embryos do not show robust alterations in gene expression, except for a trending increase in α- and β-cell markers at E17.5 and P2. Note, that Amy2
expression levels are three orders of magnitude lower at E13.5 than in later stages. n= 7–11 (E13.5, indZeb1), n= 5 (E13.5, Zeb1Δ/Δpanc); n= 7–9
(E15.5, indZeb1), n= 3–4 (E15.5, Zeb1Δ/Δpanc); n= 5–6 (E17.5, indZeb1), n= 7–8 (E17.5, Zeb1Δ/Δpanc); n= 7–9 (P2, indZeb1), n= 5–6 (P2, Zeb1Δ/Δpanc).
B qRT-PCR analysis of Zeb1-regulated microRNAs in RNA extracted from the pancreas of indZeb1/ctrl and Zeb1Δ/Δpanc/Zeb1fl/fl littermates at E17.5 and
P2. All analyzed microRNAs show a significant reduction in indZeb1 specimens in at least one stage, whereas no clear difference is observed in
Zeb1Δ/Δpanc miRNA levels compared to controls. n= 5–6 (E17.5, indZeb1), n= 7–8 (E17.5, Zeb1Δ/Δpanc); n= 7–9 (P2, indZeb1), n= 5–6 (P2,
Zeb1Δ/Δpanc). Statistical significance was determined by two-way ANOVA or Student’s t-test and indicated if significance was reached. ***p= 0.0004,
p= 0.0001; **p= 0.0023, p= 0.0014, p < 0.005 (mRNA, E13.5); ***p= 0.0002, p= 0.0002; **p= 0.0013, p= 0.0072; *p= 0.019 (mRNA, E15.5); *p=
0.021, p= 0.012, p= 0.027, p= 0.013, p= 0.012, p= 0.028 (mRNA, E17.5); ***p= 0.0047; ***p= 0.0004, p= 0.0002; **p= 0.0010; *p= 0.014 (mRNA,
P2); *p= 0.026, p= 0.009, p= 0.035, p= 0.041 (miRNA, E13.5); *p= 0.020, p= 0.038 (miRNA, E15.5); **p= 0.009, p= 0.007, p= 0.004; *p= 0.011
(miRNA, E17.5); **p= 0.0014, p= 0.0036 (miRNA, P2).
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Among several important miRNAs the miR-200 family
is a powerful regulator of pancreas function44. Members
of this family are upregulated during diabetes and drive
β-cell apoptosis, whereas hyperglycemia and β-cell
apoptosis can be inhibited by ablation of miR-200s47. In a
rat cell culture model of β-cells (INS-1), knockdown of
Zeb1 was sufficient to induce apoptosis by upregulated
miR-200s48. In our in vivo analyses we observed a similar
anti-correlated relationship leading to miR-200s down-
regulation when Zeb1 was experimentally increased.
However, we neither observed a miR-200 mediated
increase in apoptosis upon Zeb1 knockout nor reduced
cell death upon Zeb1 overexpression, but rather opposite
effects. This indicates that the role of Zeb1 and miRNAs
in the pancreas is more complex, maybe stage-specific and
different in acini and islets. Spatiotemporal differences in
activities of the rat insulin47 and mouse Pdx1 promoters
to drive gene deletion/activation may also contribute to
opposing findings.
Why does a moderate overexpression of Zeb1 result in
such a strong pancreas hypoplasia? Interestingly, Zeb1
overexpression during hematopoiesis or widespread Snai1
and Snai2 overexpression in mice that includes the pan-
creas did not show such dramatic effects42,50,53,54. In
contrast to depletion of Pdx1, Ptf1a or Mnx1, which
shows early defects in initial pancreatic bud formation or
expansion7,9,10,55, we here observed no effect on bud
formation but on specification of exocrine, endocrine, and
duct lineages later due to impaired cell survival and
proliferation resulting in hyperplasia. Although we
observed major downregulation of endocrine-specific
genes—an indication that endocrine cells are more
severely affected— our phenotype is different from other
loss- and gain-of function mutations. For example,
Ngn3−/−, Neurod1−/−, Nkx2-2−/− and Nkx6-1−/− mice
display reduced or absent endocrine lineages, β-cell dif-
ferentiation, and/or reduction in islet size43,56–58, e.g., due
to endocrine to acinar fate switch16. The fact that Zeb1
affects cell survival and proliferation of all pancreas
lineages is in agreement with its capacity to completely
reprogram cells during EMT in cancer, leading to ample
changes in cellular properties including metabolism and
cell architecture22,27. Consequently, these findings sup-
port the hypothesis that Zeb1 expression is required for
specific functions, but needs to be tightly regulated and
thus kept at a low level for proper organ function.
Interestingly, Zeb1 deficiency resulted in pronounced
liver steatosis indicating systemic consequences of
pancreas-specific Zeb1 depletion. How Zeb1 is integrated
in the complex regulation of diabetes, sex steroids, fatty
liver, increase of visceral fat and pancreas steatosis still
remains obscure. Obesity, hyperglycemia, insulin resis-
tance, and GTT correlate with liver steatosis59–62. Pan-
creas dysfunction during diabetes stimulates peripheral
lipolysis, the release of free fatty acids, and deposition in
the liver which also correlates with pancreas lipoma-
tosis63–66. Moreover, insulin resistance is increasing the
portal flux of fatty acids facilitating adipokine release by
pancreas adipocytes, which fosters free fatty acids in the
circulation and liver steatosis65,66. In line with this, our
mice that show steatosis in the pancreas but not in the
liver might display the priming of this vicious cycle,
whereas the presence of a fatty liver in obese diabetic mice
indicates a more progressed disease state. Despite the
small sample size in our experiments, it is tempting to
speculate that Zeb1 attenuates disease pathology by
inhibiting pancreas lipid deposition and liver steatosis. To
test this hypothesis a more detailed analysis is required.
In conclusion, our findings indicate that Zeb1 function
in the pancreas is indispensable for proper morphogenesis
and homeostasis requiring very tight locus control to
maintain low Zeb1 expression levels.
Materials and methods
Mice
Animal husbandry and all experiments were per-
formed according to the European Animal Welfare laws
and guidelines. The protocols were approved by the
committee on ethics of animal experiments of Bavaria,
Germany (Regierung von Unterfranken, Würzburg; TS-
18/14 and 55.2-DMS-2532-2-59). Power analysis was
used to calculate the sample size required for animal
experiments. Animals were kept on a 12:12 h light-dark
cycle and provided with food and water ad libitum in
the animal facility of the Friedrich-Alexander Uni-
versity of Erlangen-Nürnberg. The Pdx1-Cre transgene
(Tg(Pdx1-cre)6Tuv), generation of the conditional Zeb1
knockout alleles, Zeb1fl (Zeb1tm1.1Mpst) and Zeb1del
(Zeb1tm1.2Mpst) as well as the mTmG Cre reporter (Gt
(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) have been
described previously29,36,37. Coding sequences of HA-
tagged Zeb1 were inserted into the Rosa26 locus for
Cre-mediated gene activation42. A detailed description
of R26-Zeb1tg mice will be described elsewhere. All
mice were kept on a C57BL/6N background. Mice were
sacrificed at indicated timepoints and tissues were fixed
in 4% paraformaldehyde (PFA)/PBS overnight and
embedded into paraffin, fresh frozen in TissueTek OCT
at −80 °C or subjected to RNA isolation.
Induction of type 2 diabetes and CP
For induction of type 2 diabetes (T2D) mice were
switched from normal chow diet (ND) to HFD with
60 kJ % fat (Ssniff, Soest, Germany) directly after
weaning for 19–20 weeks40. Mice under HFD and con-
trol ND were weighed and venous blood glucose levels
measured at indicated time-points to assess T2D
progression.
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CP was induced by hydrodynamic gene delivery of an
Il17a expression vector into the liver, using a mouse
Albumin promoter/Afp enhancer sequence of pLIVE
(Mirus, Madison, WI, USA) to drive mouse Il17a
expression41.
GTT and measurement of blood glucose and insulin levels
For the intraperitoneal GTT mice were fasted for 4–6 h
and injected intraperitoneally with 2 g/kg body weight
glucose38,40. Venous blood samples were taken before and
during GTT at indicated time-points and blood glucose
concentrations were measured with a glucometer (VPD,
Bled, Slovenia). For quantification of insulin levels, plasma
was isolated from the supernatant after centrifugation of
blood samples for 15min at 2000 × g at 4 °C. Quantifica-
tion was carried out by the Ultra Sensitive Mouse Insulin
ELISA Kit (Crystal Chem, Zaandam, Netherlands)
according to the manufacturer’s instructions.
Statistical analysis
Prism 8 (GraphPad, San Diego, CA, USA) was used for
statistical analysis. Data are represented by means ± SEM
of n biological replicates as indicated. One-way ANOVA
with Tukey multiple comparisons test was used to analyze
ratios of pancreas weight versus total body weight, for
quantification of Insulin/Glut2-areas and for proliferation
and apoptosis. Two-way ANOVA with Tukey multiple
comparisons test or Student’s t-test was used for qRT-
PCR data for Zeb1fl/fl, Zeb1+/Δpanc, and Zeb1Δ/Δpanc. qRT-
PCR data between E13.5 and P2, proliferation and apop-
tosis, GTT, glucose and Insulin levels, liver weight and
steatosis were analyzed by Student’s multiple t-test, cor-
rected for multiple comparisons, and the Holm-Sidak
method for correction. Survival of indZeb1 was tested for
significance by a log-rank (Mantel-Cox) test. In all ana-
lyses two-tailed tests were performed. P-values of statis-
tical significance are represented as: *p < 0.05, **p < 0.01,
***p < 0.001. The variance between the statistically com-
pared groups are similar. No estimate of variation has
been performed within each group of data prior to sta-
tistical analysis.
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